Please enable Javascript
Localized Prostate Cancer
Advertisement
Enzalutamide Plus Leuprolide Improves Metastasis-Free Survival in Non-metastatic Prostate Cancer
Emily Menendez
Localized Prostate Cancer
|
March 21, 2023
A study arm from the phase 3 EMBARK trial evaluating enzalutamide for nmCSPC with high-risk BCR has had positive outcomes.
Read More
Analyzing 15-Year Follow-up Outcomes After Prostate Cancer Treatment
Emily Menendez
Localized Prostate Cancer
|
March 13, 2023
A recent study analyzed a 15-year follow-up in men with prostate cancer to gauge the effectiveness of different treatments.
Read More
Cost of Localized Prostate Cancer Care Impacts Decision-Making for Clinicians, Patients
Akhil Abraham Saji, MD
Localized Prostate Cancer
|
February 28, 2023
This review highlights the research on the costs related to the treatment of localized PC and the associated outcomes.
Read More
Novel Approaches for Risk Stratifying Newly Diagnosed Localized Prostate Cancer
Phouc T. Tran, MD, PhD
ASCO GU Symposium 2023
|
February 24, 2023
Phouc Tran, MD, PhD, highlights the challenges of accurate risk stratification for newly diagnosed localized prostate cancer.
View More
Novel Guidelines for PSMA PET Staging of Localized Prostate Cancer
David Nanus, MD
ASCO GU Symposium 2023
|
February 17, 2023
David Nanus, MD, details the ways in which PSMA PET varies in guidelines and is used to stage localized prostate cancer.
View More
MRI-Guided Versus CT-Guided Stereotactic Body Radiotherapy for Prostate Cancer
Emily Menendez
Localized Prostate Cancer
|
January 23, 2023
A recent update on the phase 3 MIRAGE trial determined if MRI or CT-guided stereotactic body radiotherapy is most effective.
Read More
PROs After EBRT With Brachytherapy Boost Versus Prostatectomy for Localized Prostate Cancer
David Ambinder, MD
Localized Prostate Cancer
|
January 18, 2023
With a lack of trials that address different surgical options for localized PC, is there evidence to guide patients?
Read More
Association Between Baseline Fatigue and OS After SBRT for Localized Prostate Cancer
Emily Menendez
Localized Prostate Cancer
|
January 10, 2023
A recent study investigated the role of FACIT-F as a baseline predictor for OS in patients undergoing SBRT for localized PCa.
Read More
Baseline 4Kscore Predicts Progression on Active Surveillance in Prostate Cancer
Zachary Bessette
Localized Prostate Cancer
|
December 14, 2022
A prospective study assessed the 4Kscore’s ability to predict prostate cancer tumor progression on active surveillance.
Read More
PET-CT Versus SPECT for Prostate Cancer at High Risk for Skeletal Metastases
Zachary Bessette
Localized Prostate Cancer
|
December 5, 2022
18F-sodium fluoride positron emission tomography-computed tomography may better detect skeletal metastases in patients
Read More
Whole Gland Cryoablation Had Good Outcomes for Localized Prostate Cancer
Leah Lawrence
Localized Prostate Cancer
|
October 12, 2022
The use of primary whole gland cryoablation had excellent outcomes among men with localized prostate cancer.
Read More
AS Plus Enzalutamide Monotherapy Versus AS Alone for Localized Prostate Cancer
David Ambinder, MD
Journal
|
July 27, 2022
Active surveillance and enzalutamide monotherapy for localized prostate cancer is compared with active surveillance alone.
Read More
New Focal Ablation Therapy Yields Low Rate of Significant Prostate Cancer
Leah Lawrence
Localized Prostate Cancer
|
July 21, 2022
The rate of prostate cancer after high-frequency irreversible electroporation ablation was lower than other energy platforms.
Read More
The Long-Term Effect of Intensity Modulated Radiation Therapy for Prostate Cancer on Testosterone Levels
GU Oncology Now Editors
Localized Prostate Cancer
|
June 1, 2022
...
Read More
Salvage Prostate Stereotactic Body Radiation Therapy After Definitive Cryoablation
GU Oncology Now Editors
Localized Prostate Cancer
|
June 1, 2022
...
Read More
Enrichment of "Cribriform" morphologies (intraductal and cribriform adenocarcinoma) and genomic alterations in radiorecurrent prostate cancer
GU Oncology Now Editors
Localized Prostate Cancer
|
May 24, 2022
...
Read More
Medical Resource Consumption of Radical Prostatectomy Versus Intensity-Modulated Radiotherapy for Old Patients With Prostate Cancer
GU Oncology Now Editors
Localized Prostate Cancer
|
May 20, 2022
The propensity score matching investigated the medical expenditure of RP and IMRT in elderly patients with high-risk LPC.
Read More
Study Confirms That Localized Prostate Cancer Exerts Significant Mental Health Burdens
Vanessa Ira
AUA 2022
|
May 18, 2022
The mental health data comes from one of the largest randomized-controlled trials to date.
Read More
Repeat Focal Therapy After Treatment Failure Improves Functional Outcome in Prostate Cancer
Vanessa Ira
AUA 2022
|
May 16, 2022
The therapy represents a valuable strategy in select patients whose disease fails to respond to initial cryoablation or HIFU.
Read More
Surgery Improves Urinary Tract Symptoms in Localized Prostate Cancer Better Than Radiation
Vanessa Ira
AUA 2022
|
May 16, 2022
The results highlight the need for urologists to consider baseline urinary symptoms in treatment decision-making.
Read More
Load More
Advertisement
Advertisement
Advertisement